Cite
HARVARD Citation
Musso, M. et al. (2016). Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine‐based high‐dose chemotherapy regimen. British journal of haematology. pp. 111-121. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Musso, M. et al. (2016). Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine‐based high‐dose chemotherapy regimen. British journal of haematology. pp. 111-121. [Online].